Total antioxidant capacity and total oxidant status after surfactant treatment in preterm infants with respiratory distress syndrome

Annals of Clinical Biochemistry

Volumn 48, Issue 5, 2011, Pages 462-467

  Dizdar, Evrim Alyamac ^a   Uras, Nurdan ^a   Oguz, Suna ^a   Erdeve, Omer ^a   Sari, Fatma Nur ^a   Aydemir, Cumhur ^a   Dilmen, Ugur ^a  

^a Zekai Tahir Burak Maternity and Teaching Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HYDROGEN PEROXIDE; LIPID HYDROPEROXIDE; PORACTANT; 2,2' AZINO DI (3 ETHYLBENZOTHIAZOLINE) 6 SULFONIC ACID; 2,2'-AZINO-DI-(3-ETHYLBENZOTHIAZOLINE)-6-SULFONIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BENZOTHIAZOLE DERIVATIVE; BILIRUBIN; BIOLOGICAL PRODUCT; GLUTATHIONE; LIPID PEROXIDE; LUNG SURFACTANT; PHOSPHOLIPID; SULFONIC ACID DERIVATIVE; URIC ACID;

APGAR SCORE; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; DEATH; FOLLOW UP; GESTATIONAL AGE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LUNG DYSPLASIA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATENT DUCTUS ARTERIOSUS; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; ADULT; BLOOD; CHEMISTRY; FEMALE; MALE; METABOLISM; OXIDATIVE STRESS; PREGNANCY;

TOSCANA VIRUS;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BENZOTHIAZOLES; BILIRUBIN; BIOLOGICAL AGENTS; FEMALE; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; INFANT, NEWBORN; INFANT, PREMATURE; LIPID PEROXIDES; MALE; OXIDATIVE STRESS; PHOSPHOLIPIDS; PREGNANCY; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SULFONIC ACIDS; TREATMENT OUTCOME; URIC ACID; VITAMIN E; YOUNG ADULT;

EID: 84855181880     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2011.010285     Document Type: Article

References (48)

1. Gitto E, Reiter RJ, Karbownik M, Xian-Tan D, Barberi I. Respiratory distress syndrome in the newborn: role of oxidative stress. Intensive Care Med 2001;27:1116-23
2. Saugstad OD. Update on oxygen radical disease in neonatology. Curr Opin Obstet Gynecol 2001;13:147-53
3. Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010;15:191-5
4. Kumar VH, Patel A, Swartz DD, et al. Exposure to supplemental oxygen and its effects on oxidative stress and antioxidant enzyme activity in term newborn lambs. Pediatr Res 2010;67:66-71
5. Patel A, Lakshminrusimha S, Ryan RM, et al. Exposure to supplemental oxygen downregulates antioxidant enzymes and increases pulmonary arterial contractility in premature lambs. Neonatology 2009;96:182-92
6. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 2002;122:314S-20S
7. Frank L, Sosenko IR. Prenatal development of lung antioxidant enzymes in four species. J Pediatr 1987;110:106-10
8. Rodriguez RJ, Martin RJ, Fanaroff AA. The respiratory distress syndrome and its management. In: Fanaroff AA, Martin RJ, eds. Neonatal Perinatal Medicine: Diseases of the Fetus and Infant. St. Louis, MO: Mosby, 2006: 1097-107
9. Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 1999;27:1738-44
10. Huertas JR, Palomino N, Ochoa JJ, et al. Lipid peroxidation and antioxidants in erythrocyte membranes of full-term and preterm newborns. Biofactors 1998;8:133-7
11. Moison RM, de Beaufort AJ, Haasnoot AA, Dubbelman TM, van Zoeren-Grobben D, Berger HM. Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease. Free Radic Biol Med 1997;23:226-34
12. Boda D, Nemeth I, Pinter S. Surface tension, glutathione content and redox ratio of the tracheal aspirate fluid of premature infants with IRDS. Biol Neonate 1998;74:281-8
13. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett 1994;349:197-200
14. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993;84:407-12
15. Ogihara T, Okamoto R, Kim HS, et al. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 1996;39:117-9
16. Farkas I, Maroti Z, Katona M, et al. Increased heme oxygenase-1 expression in premature infants with respiratory distress syndrome. Eur J Pediatr 2008;167:1379-83
17. Contreras M, Hariharan N, Lewandoski JR, Ciesielski W, Koscik R, Zimmerman JJ. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 1996;24:29-37
18. Van Zoeren-Grobben D, Lindeman JH, Houdkamp E, Moison RM, Wijnen JT, Berger HM. Markers of oxidative stress and antioxidant activity in plasma and erythrocytes in neonatal respiratory distress syndrome. Acta Pediatr 1997;86:1356-62
19. Frosali S, Di Simplicio P, Perrone S, et al. Glutathione recycling and antioxidant enzyme activities in erythrocytes of term and preterm newborns at birth. Biol Neonate 2004;85:188-94
20. Hamon I, Fresson J, Nicolas MB, Buchweiller MC, Franck P, Hascoet JM. Early inhaled nitric oxide improves oxidative balance in very preterm infants. Pediatr Res 2005;57:637-43
21. Lindeman JH, van Zoeren-Grobben D, Schrijver J, Speek AJ, Poorthuis BJ, Berger HM. The total free radical trapping ability of cord blood plasma in preterm and term babies. Pediatr Res 1989;26:20-4
22. Loewen GM, Holm BA, Milanowski L, Wild LM, Notter RH, Matalon S. Alveolar hyperoxic injury in rabbits receiving exogenous surfactant. J Appl Physiol 1989;66:1087-92
23. Matalon S, Holm BA, Notter RH. Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J Appl Physiol 1987;62:756-61
24. Jain D, Atochina-Vasserman EN, Tomer Y, Kadire H, Beers MF. Surfactant protein D protects against acute hyperoxic lung injury. Am J Respir Crit Care Med 2008;178:805-13
25. Bridges JP, Davis HW, Damodarasamy M, et al. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 2000;275:38848-55
26. Dani C, Buonocore G, Longini M, et al. Superoxide dismutase and catalase activity in naturally derived commercial surfactants. Pediatr Pulmonol 2009;44:1125-31
27. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85
28. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11
29. Sinha SK, Gupta S, Donn SM. Immediate respiratory management of the preterm infant. Semin Fetal Neonatal Med 2008;13:24-9
30. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9
31. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991;11:463-94
32. Georgeson GD, Szony BJ, Streitman K, et al. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol 2002;103:136-9
33. Gitto E, Pellegrino S, D'Arrigo S, Barberi I, Reiter RJ. Oxidative stress in resuscitation and in ventilation of newborns. Eur Respir J 2009;34:1461-9
34. Ramanathan R. Choosing a right surfactant for respiratory distress syndrome treatment. Neonatology 2009;95:1-5
35. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-49
36. Lubec G, Widness JA, Hayde M, Menzel D, Pollak A. Hydroxyl radical generation in oxygen-treated infants. Pediatrics 1997;100:700-4
37. Schock BC, Sweet DG, Halliday HL, Young IS, Ennis M. Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2001;281:L1386-91
38. Ballard PL, Truog WE, Merrill JD, et al. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics 2008;121:555-61
39. Lorch SA, Banks BA, Christie J, et al. Plasma 3-nitrotyrosine and outcome in neonates with severe bronchopulmonary dysplasia after inhaled nitric oxide. Free Radic Biol Med 2003;34:1146-52
40. Winterbourn CC, Chan T, Buss IH, Inder TE, Mogridge N, Darlow BA. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr Res 2000;48:84-90
41. Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009;124:e439-49
42. May C, Patel S, Kennedy C, et al. Prediction of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2011 [E-pub ahead of print] DOI: 10.1136/adc.2010.189597
43. Ahola T, Levonen AL, Fellman V, Lapatto R. Thiol metabolism in preterm infants during the first week of life. Scand J Clin Lab Invest 2004;64:649-58
44. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367:1421-31
45. Greenough A. Prenatal factors in the development of chronic lung disease. Semin Fetal Neonatal Med 2009;14:339-44
46. Kuint J, Reichman B, Neumann L, Shinwell ES. Prognostic value of the immediate response to surfactant. Arch Dis Child Fetal Neonatal Ed 1994;71:F170-3
47. Van Lierde S, Smith J, Devlieger H, Eggermont E. Outcome of respiratory distress syndrome at 28 days: a prospective longitudinal study. Eur Respir J 1992;5:1243-8
48. Bick U, Muller-Leisse C, Troger J, et al. Therapeutic use of surfactant in neonatal respiratory distress syndrome. Correlation between pulmonary X-ray changes and clinical data. Pediatr Radiol 1992;22: 169-73